Surveillance and monitoring of hepatocellular carcinoma.
Quantitative Liquid Chromatography/Immunoassay
This test is New York DOH approved.
- Patient Preparation
- Plain red or serum separator tube.
- Specimen Preparation
- Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
- Storage/Transport Temperature
- Unacceptable Conditions
- After separation from cells: Ambient: 8 hours; Refrigerated: 1 week; Frozen: 3 months (avoid repeated freeze/thaw cycles)
Effective August 20, 2012
0.0 - 7.4 ng/mL
The µTASWako method is used. Results obtained with different assay methods or kits cannot be used interchangeably. The des-gamma-carboxy prothrombin (DCP) assay is intended as a risk assessment for the development of hepatocellular carcinoma in patients with chronic liver diseases. Elevated DCP values have been shown to be associated with an increased risk for developing hepatocellular carcinoma. Patients with elevated serum DCP should be more intensely evaluated for evidence of hepatocellular carcinoma.
|Component Test Code*||Component Chart Name|
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at firstname.lastname@example.org.